Date Action Amount Person Type
Feb 16, 2024 Sell 6 812 Van Houte Hans Common Stock
Feb 13, 2024 Buy 150 000 Van Houte Hans Employee Stock Option (right to buy)
Feb 13, 2024 Buy 45 000 Van Houte Hans Restricted Stock Units
Feb 13, 2024 Buy 150 000 Ring Christine Employee Stock Option (right to buy)
Feb 13, 2024 Buy 45 000 Ring Christine Restricted Stock Units
Feb 13, 2024 Buy 150 000 Hansen Gwenn Employee Stock Option (right to buy)
Feb 13, 2024 Buy 45 000 Hansen Gwenn Restricted Stock Units
Feb 13, 2024 Buy 800 000 Sands Arthur T Employee Stock Option (right to buy)
Jan 30, 2024 Buy 2 000 Van Houte Hans Common Stock
Jan 30, 2024 Sell 1 671 Van Houte Hans Common Stock
Jan 30, 2024 Buy 2 886 Van Houte Hans Common Stock
Jan 30, 2024 Sell 2 886 Van Houte Hans Restricted Stock Units
Jan 30, 2024 Sell 2 000 Van Houte Hans Restricted Stock Units
Jan 30, 2024 Buy 2 000 Hansen Gwenn Common Stock
Jan 30, 2024 Buy 3 207 Hansen Gwenn Common Stock
Jan 30, 2024 Sell 2 334 Hansen Gwenn Common Stock
Jan 30, 2024 Sell 3 207 Hansen Gwenn Restricted Stock Units
Jan 30, 2024 Sell 2 000 Hansen Gwenn Restricted Stock Units
Jan 30, 2024 Buy 2 000 Ring Christine Common Stock
Jan 30, 2024 Sell 2 000 Ring Christine Restricted Stock Units
Jan 30, 2024 Sell 1 760 Ring Christine Common Stock
Jan 30, 2024 Buy 1 924 Ring Christine Common Stock
Jan 30, 2024 Sell 1 924 Ring Christine Restricted Stock Units
Dec 20, 2023 Sell 3 541 Van Houte Hans Common Stock
Dec 19, 2023 Sell 10 906 Van Houte Hans Common Stock
Oct 31, 2023 Sell 1 080 Van Houte Hans Common Stock
Oct 31, 2023 Sell 1 232 Ring Christine Common Stock
Oct 31, 2023 Sell 1 633 Hansen Gwenn Common Stock
Oct 30, 2023 Buy 2 000 Van Houte Hans Common Stock
Oct 30, 2023 Buy 2 886 Van Houte Hans Common Stock
Oct 30, 2023 Sell 2 886 Van Houte Hans Restricted Stock Units
Oct 30, 2023 Sell 2 000 Van Houte Hans Restricted Stock Units
Oct 30, 2023 Sell 2 000 Ring Christine Restricted Stock Units
Oct 30, 2023 Sell 1 924 Ring Christine Restricted Stock Units
Oct 30, 2023 Buy 2 000 Ring Christine Common Stock
Oct 30, 2023 Buy 1 924 Ring Christine Common Stock
Oct 30, 2023 Buy 2 000 Hansen Gwenn Common Stock
Oct 30, 2023 Buy 3 207 Hansen Gwenn Common Stock
Oct 30, 2023 Sell 3 207 Hansen Gwenn Restricted Stock Units
Oct 30, 2023 Sell 2 000 Hansen Gwenn Restricted Stock Units
Jul 31, 2023 Sell 1 245 Van Houte Hans Common Stock
Jul 31, 2023 Sell 1 420 Ring Christine Common Stock
Jul 31, 2023 Sell 1 884 Hansen Gwenn Common Stock
Jul 30, 2023 Buy 2 000 Van Houte Hans Common Stock
Jul 30, 2023 Buy 2 886 Van Houte Hans Common Stock
Jul 30, 2023 Sell 2 886 Van Houte Hans Restricted Stock Units
Jul 30, 2023 Sell 2 000 Van Houte Hans Restricted Stock Units
Jul 30, 2023 Sell 2 000 Ring Christine Restricted Stock Units
Jul 30, 2023 Sell 1 924 Ring Christine Restricted Stock Units
Jul 30, 2023 Buy 2 000 Ring Christine Common Stock
Jul 30, 2023 Buy 1 924 Ring Christine Common Stock
Jul 30, 2023 Sell 3 207 Hansen Gwenn Restricted Stock Units
Jul 30, 2023 Buy 2 000 Hansen Gwenn Common Stock
Jul 30, 2023 Buy 3 207 Hansen Gwenn Common Stock
Jul 30, 2023 Sell 2 000 Hansen Gwenn Restricted Stock Units
May 04, 2023 Buy 25 000 Silva Paul M Director Stock Option (right to buy)
May 04, 2023 Buy 25 000 Saltzman Edward C Director Stock Option (right to buy)
May 04, 2023 Buy 25 000 Reinsdorf Judith A Director Stock Option (right to buy)
May 04, 2023 Buy 25 000 Lacey David L. Director Stock Option (right to buy)
May 04, 2023 Buy 25 000 Kunkel Lori Anne Director Stock Option (right to buy)
May 04, 2023 Buy 25 000 Gregory Julia P Director Stock Option (right to buy)
May 01, 2023 Sell 342 Wolff Stefani Common Stock
May 01, 2023 Sell 721 Van Houte Hans Common Stock
May 01, 2023 Sell 682 Ring Christine Common Stock
May 01, 2023 Sell 1 136 Hansen Gwenn Common Stock
Apr 30, 2023 Sell 962 Wolff Stefani Restricted Stock Units
Apr 30, 2023 Buy 962 Wolff Stefani Common Stock
Apr 30, 2023 Buy 2 886 Van Houte Hans Common Stock
Apr 30, 2023 Sell 2 886 Van Houte Hans Restricted Stock Units
Apr 30, 2023 Sell 1 924 Ring Christine Restricted Stock Units
Apr 30, 2023 Buy 1 924 Ring Christine Common Stock
Apr 30, 2023 Sell 3 206 Hansen Gwenn Restricted Stock Units
Apr 30, 2023 Buy 3 206 Hansen Gwenn Common Stock
Feb 14, 2023 Buy 88 900 Wolff Stefani Employee Stock Option (right to buy)
Feb 14, 2023 Buy 24 000 Wolff Stefani Restricted Stock Units
Feb 14, 2023 Buy 88 900 Van Houte Hans Employee Stock Option (right to buy)
Feb 14, 2023 Buy 24 000 Van Houte Hans Restricted Stock Units
Feb 14, 2023 Buy 448 000 Sands Arthur T Employee Stock Option (right to buy)
Feb 14, 2023 Buy 88 900 Ring Christine Employee Stock Option (right to buy)
Feb 14, 2023 Buy 24 000 Ring Christine Restricted Stock Units
Feb 14, 2023 Buy 88 900 Hansen Gwenn Employee Stock Option (right to buy)
Feb 14, 2023 Buy 24 000 Hansen Gwenn Restricted Stock Units
Jan 30, 2023 Sell 962 Wolff Stefani Restricted Stock Units
Jan 30, 2023 Buy 962 Wolff Stefani Common Stock
Jan 30, 2023 Sell 424 Wolff Stefani Common Stock
Jan 30, 2023 Buy 2 886 Van Houte Hans Common Stock
Jan 30, 2023 Sell 924 Van Houte Hans Common Stock
Jan 30, 2023 Sell 2 886 Van Houte Hans Restricted Stock Units
Jan 30, 2023 Sell 1 924 Ring Christine Restricted Stock Units
Jan 30, 2023 Buy 1 924 Ring Christine Common Stock
Jan 30, 2023 Sell 848 Ring Christine Common Stock
Jan 30, 2023 Sell 3 207 Hansen Gwenn Restricted Stock Units
Jan 30, 2023 Buy 3 207 Hansen Gwenn Common Stock
Jan 30, 2023 Sell 1 412 Hansen Gwenn Common Stock
Oct 31, 2022 Sell 739 Van Houte Hans Common Stock
Oct 31, 2022 Sell 699 Ring Christine Common Stock
Oct 30, 2022 Buy 2 886 Van Houte Hans Common Stock
Oct 30, 2022 Sell 2 886 Van Houte Hans Restricted Stock Units
Oct 30, 2022 Sell 1 924 Ring Christine Restricted Stock Units
Oct 30, 2022 Buy 1 924 Ring Christine Common Stock
INSIDER POWER
82.639
Last 100 transactions
Buy: 2 499 418 | Sell: 108 263 (Shares)

Based on the 100 latest insides trades, we have calculated the insider power to be positive at a ratio of 82.639.

In total, the insiders bought 2 499 418 and sold 108 263 NRIX shares in the last 100 trades.

Click to get the best stock tips daily for free!

About Nurix Therapeutics, Inc.

Nurix Therapeutics. Nurix Therapeutics, Inc., a biopharmaceutical company, focuses on the discovery, development, and commercialization of small molecule therapies for the treatment of cancer and immune disorders. The company develops NX-2127, an orally available Bruton's tyrosine kinase (BTK) degrader for the treatment of relapsed or refractory B-cell malignancies; NX-5948, an orally bioavailable BTK degrader for the treatment of relapsed or refractory B-cell malig... NRIX Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT